Search clinical trials for: Angiotensin-Converting Enzyme Inhibitors

Total 47036 results

Nanfang Hospital of Southern Medical University

Terminated

Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency (SDBRAS)

Renal Insufficiency, Chronic

China
Novartis

Completed

Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes

Hypertension

Germany
Novartis Pharmaceuticals

Completed

Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension

Hypertension

United States, Belgium, France, Germany, Hungary, India, Italy, Poland, Turkey
Assistance Publique - Hôpitaux de Paris
Danone Institute International

Terminated

Effects of Peptides Derived From Fermented Milk on Blood Pressure Regulation System in Healthy Volunteers.

Healthy

France
Hamilton Health Sciences Corporation

Completed

Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization

Kidney Failure

Canada
Istituto Auxologico Italiano
Italian Society of Hypertension; Italian Society of General Practitioners; Yghea

Terminated

Prevention of Diabetes and Hypertension (PHIDIAS)

Hypertension | Diabetes Mellitus

Italy
National Taiwan University Hospital

Completed

Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism

Hyperaldosteronism

Taiwan
Boehringer Ingelheim

Completed

Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers

Healthy
University of Pennsylvania
University of Arizona; Jordana B. Cohen, MD, MSCE; Thomas C. Hanff, MD, MPH; Department... and other collaborators

Completed

Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 (REPLACECOVID)

COVID-19

United States
Ethicare GmbH

Unknown

Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease (LENA-WP09)

Heart Failure | Congenital Heart Disease

Austria, United Kingdom, Hungary, Netherlands, Serbia
Merck Sharp & Dohme LLC
Actelion

Completed

A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)

Hypertension
Ethicare GmbH

Unknown

Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy (LENA-WP08)

Heart Failure | Dilated Cardiomyopathy

Austria, United Kingdom, Hungary, Netherlands, Serbia
Yaounde Central Hospital
University of Yaounde 1

Completed

Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes (CHRONIC1)

Hypertension | Diabetes Mellitus, Type 2
National Institute of Diabetes and Digestive and...
Washington University School of Medicine; Merck Sharp & Dohme LLC; University... and other collaborators

Completed

HALT Progression of Polycystic Kidney Disease Study B (HALT PKD B)

Kidney, Polycystic

United States
West China Hospital

Not yet recruiting

The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction (PERI-STEMI)

STEMI

China
Yaounde Central Hospital

Completed

Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients (CARE-PLP)

Type 2 Diabetes Mellitus

Cameroon
Novartis

Completed

Antiproteinuric Effect of Valsartan and Lisinopril

Hypertension | Diabetic Nephropathy

Switzerland
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers

Healthy
University of Pavia

Unknown

Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension

Essential Hypertension

Italy
University Ghent

Completed

Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension (Lisi-ped)

Primary Hypertension | Secondary Hypertension

Belgium
John Paul II Hospital, Krakow

Not yet recruiting

The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction (CRACOVIA-HF)

Heart Failure With Moderately Reduced Ejection Fraction
Clinical Hospital Heliodor Swiecicki of the Medical...
Medical University of Silesia; Medical University of Gdansk; Medical University... and other collaborators

Recruiting

Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction (PRESENT-HF)

Heart Failure

Poland
Nationwide Children's Hospital
Boston Children's Hospital; University of California, Davis; University of Minnesota and other collaborators

Completed

Cardiomyopathy in DMD: Lisinopril vs. Losartan

Cardiomyopathy | Duchenne Muscular Dystrophy (DMD)

United States
Novartis Pharmaceuticals

Completed

COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure (CONFIDENCE-HF)

Heart Failure | Erectile Dysfunction | Heart Failure, Systolic

Germany
Mansoura University

Recruiting

Effect of Sodium-glucose Cotransporter-2 Inhibitors (SGLT-2i) on Proteinuria in Nephrotic Children Older Than 10 Years

Nephrotic Syndrome in Children

Egypt
University Hospital, Gentofte, Copenhagen

Completed

Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19 (RASCOVID-19)

Covid-19

Denmark
Sergey V. Nedogoda

Unknown

Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome (COMPOSER)

Metabolic Syndrome | Arterial Hypertension

Russian Federation
Manchester University NHS Foundation Trust

Completed

Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia (PICk-UP)

Cardiovascular Diseases | Pre-Eclampsia Onset Less Than 37 Weeks (Diagnosis)

United Kingdom
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer

Unspecified Childhood Solid Tumor, Protocol Specific | Cardiac Toxicity

United States, Canada, Switzerland
Charles Drew University of Medicine and Science

Completed

Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria (END-IT)

Microalbuminuria

United States
Novartis

Completed

A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension

Hypertension

United States, Argentina, Colombia, France, Germany, India, Spain
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions

Healthy

India
Eastern Virginia Medical School

Withdrawn

Lisinopril for Renal Protection in Postpartum Preeclamptic Women

Preeclampsia | Microalbuminuria

United States
University Hospital, Geneva

Completed

Post-preeclampsia Renal Project: Study of Nephroprotection in Women Having Suffered Preeclampsia (RPPEC)

Renal Alteration

Switzerland
Gerstein, Hertzel, MD
Wyeth is now a wholly owned subsidiary of Pfizer; GlaxoSmithKline; Canadian Institutes... and other collaborators

Completed

The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial

Glucose Metabolism Disorders | Cardiovascular Disease | Impaired Glucose Tolerance
Novartis Pharmaceuticals

Completed

Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.

Chronic Heart Failure With Reduced Ejection Fraction

Germany
Novartis Pharmaceuticals

Active, not recruiting

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC (PARACHUTE-HF)

Heart Failure | Chagas Disease

Brazil, Argentina, Mexico, Colombia
Hospital Britanico

Completed

Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy

IGA Nephropathy

Argentina
Assistance Publique - Hôpitaux de Paris
GIS EPI-PHARE

Unknown

Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse (TRAPSAH)

AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection

France
US Department of Veterans Affairs

Terminated

VA NEPHRON-D: Diabetes iN Nephropathy Study (VA NEPHRON-D)

Type 2 Diabetes | Nephropathy | Kidney Disease

United States, Puerto Rico
Brigham and Women's Hospital

Completed

The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study (RAAS-PARC)

Hyperparathyroidism

United States
Medical University of Gdansk

Completed

Influence of Aliskiren on Proteinuria (ALIPRES)

Proteinuria | Chronic Kidney Disease | Blood Pressure

Poland
Uptal Patel
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant (PTN_LISINO)

Hypertension

United States
Gerstein, Hertzel, MD
Heart and Stroke Foundation of Ontario

Completed

The Study of Atherosclerosis With Ramipril and Rosiglitazone

Cardiovascular Disease | Atherosclerosis | Impaired Glucose Tolerance | Isolated Impaired Fasting Glucose
Natural Wellness Egypt

Not yet recruiting

NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial

Essential Hypertension
Nova Scotia Health Authority

Not yet recruiting

Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars

Hypertrophic Scar
Universiti Sains Malaysia
Ministry of Health, Malaysia

Completed

To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients

Diabetes | Impaired Glucose Tolerance

Malaysia
Steno Diabetes Center Copenhagen

Completed

Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease

Diabetic Nephropathy | Diabetes Mellitus, Type I

Denmark
Novartis Pharmaceuticals

Terminated

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure (PARADIGM-HF)

Heart Failure With Reduced Ejection Fraction

China, Germany, United States, Colombia, Korea, Republic of, Romania, South Africa, Canada, Belgium, Estonia, Hungary, Italy, Russian Federation, Taiwan, Turkey, United Kingdom, Spain, France, Netherlands, Hong Kong, Bulgaria, Israel and more

Search clinical trials for: Angiotensin-Converting Enzyme Inhibitors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations